References
- 1. SHIRAZI, L.F., BISSETT, J., ROMEO, F., MEHTA, J.L. Role of inflammation in heart failure. Current Atherosclerosis Reports. 2017; 19(6):27.
- 2. VAN LINTHOUT, S., TSCHÖPE, C. Inflammation – cause or consequence of heart failure or both?. Curr. Heart Fail. Rep. 2017; 14(4):251–265.
- 3. SETA, Y., SHAN, K., BOZKURT, B., ORAL, H., MANN, D.L. Basic mechanisms in heart failure: the cytokine hypothesis. J. Card. Fail. 1996; 2(3):243–9.
- 4. JAHNG, J.W.S., SONG, E., SWEENEY, G. Crosstalk between the heart and peripheral organs in heart failure. Exp. Mol. Med. 2016; 48(3):e217.
- 5. HARTUPEE, J., MANN, D.L. Positioning of inflammatory biomarkers in the heart failure landscape. J. Cardiovasc. Transl. Res. 2013; 6(4):485–92.
- 6. TRACCHI, I., GHIGLIOTTI, G., MURA, M., GARIBALDI, S., SPALLAROSSA, P., BARISIONE, C., et al. Increased neutrophil lifespan in patients with congestive heart failure. Eur. J. Heart Fail. 2009; 11(4):378–385.
- 7. RUDOLPH, V., RUDOLPH, T.K., HENNINGS, J.C., BLANKENBERG, S., SCHNABEL, R., STEVEN, D., et al. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic. Biol. Med. 2007; 43(8):1189–1196.
- 8. ARRUDA-OLSON, A.M., REEDER, G.S., BELL, M.R., WESTON, S.A., ROGER, V.L. Neutrophilia predicts death and heart failure after myocardial infarction: A community based study. Circ Cardiovasc Qual Outcomes 2009; 2(6):656–662.
- 9. SHAH, A.D., DENAXAS, S., NICHOLAS, O., HINGORANI, A.D., HEMINGWAY, H. Neutrophil counts and initial presentation of 12 cardiovascular diseases. JACC 2017; 69(9):1160–9.
- 10. MAISEL, A.S., KNOWLTON, K.U., FOWLER, P., REARDEN, A., ZIEGLER, M.G., MOTULSKY, H.J., et al. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J. Clin. Invest. 1990; 85(2):462–7.
- 11. VADUGANATHAN, M., GREENE, S.J., BUTLER, J., SABBAH, H.N., SHANTSILA, E., LIP, G.Y.H., et al. The immunological axis in heart failure: Importance of the leukocyte differential. Heart Fail. Rev. 2013; 18(6):835–845.
- 12. YUCEL, H., EGE, M.R., ZORLU, A., KAYA, H., BETON, O., GUNGOR, H., et al. Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction. Turk Kardiyol. Dern. Arsivi-Archives Turkish Soc. Cardiol. 2015; 43(5):427–433.
- 13. CHARACH, G., GROSSKOPF, I., ROTH, A., AFEK, A., WEXLER, D., SHEPS, D., et al. Usefulness of total lymphocyte count as predictor of outcome in patients with chronic heart failure. Am. J. Cardiol. 2011; 107(9):1353–1356.
- 14. VADUGANATHAN, M., AMBROSY, A.P., GREENE, S.J., MENTZ, R.J., SUBACIUS, H.P., MAGGIONI, A.P., et al. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction. Circ. Hear. Fail. 2012; 5(6):750–758.
- 15. BHAT, T., TELI, S., RIJAL, J., BHAT, H., RAZA, M., KHOUEIRY, G., et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev. Cardiovasc. Ther. 2013; 11(1):55–9.
- 16. ZHANG, S., DIAO, J., QI, C., JIN, J., LI, L., GAO, X., et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC Cardiovasc. Disord. 2018; 18(1):75.
- 17. PAQUISSI, F.C. The predictive role of inflammatory biomarkers in atrial fibrillation as seen through neutrophil-lymphocyte ratio mirror. J. Biomarkers 2016; 2016:1–14.
- 18. AFARI, M.E., BHAT, T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev. Cardiovasc. Ther. 2016; 14(5):573–577.
- 19. UTHAMALINGAM, S., PATVARDHAN, E. A, SUBRAMANIAN, S., AHMED, W., MARTIN, W., DALEY, M., et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am. J. Cardiol. 2011; 107(3):433–438.
- 20. BENITES-ZAPATA, V. A., HERNANDEZ, A. V., NAGARAJAN, V., CAUTHEN, C. A., STARLING, R.C., WILSON TANG, W.H. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am. J. Cardiol. 2015; 115(1):57–61.
- 21. WASILEWSKI, J., PYKA, Ł., HAWRANEK, M., OSADNIK, T., KUREK, A., SKRZYPEK, M., et al. Prognostic value of neutrophil-to-lymphocyte ratio in predicting long-term mortality in patients with ischemic and nonischemic heart failure. Pol. Arch. Med. Wewn. 2016; 126(3):166–173.
- 22. WAN, G., JI, L., XIA, W., CHENG, L., ZHANG, Y. Screening genes associated with elevated neutrophil-to-lymphocyte ratio in chronic heart failure. Mol. Med. Rep. 2018; 18(2):1415–1422.
- 23. CAKICI, M., CETIN, M., DOGAN, A., OYLUMLU, M., POLAT, M., SUNER, A. Neutrophil to lymphocyte ratio predicts poor functional capacity in patients with heart failure. Arch Turk Soc Cardiol 2014; 42(7):612–620.
- 24. TURFAN, M., ERDOGAN, E., TASAL, A., VATANKULU, M., JAFAROV, P., SONMEZ, O., et al. Neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with acute heart failure. Clinics 2014; 69(3):190–193.
- 25. OSTROWSKA, M., OSTROWSKI, A., ŁUCZAK, M., JAGUSZEWSKI, M., ADAMSKI, P., BELLWON, J., et al. Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-centre cohort. Kardiol. Pol. 2016; 75(2):157–163.
- 26. LIU, S., WANG, P., SHEN, P.-P., ZHOU, J.-H. Predictive values of red blood cell distribution width in assessing severity of chronic heart failure. Med. Sci. Monit. 2016; 22:2119–2125.
- 27. TASAL, A., ERTURK, M., UYAREL, H., KARAKURT, H., BACAKSIZ, A., VATANKULU, M.A., et al. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure. J. Cardiol. 2014; 63(6):418–423.
- 28. DURMUS, E., KIVRAK, T., GERIN, F., SUNBUL, M., SARI, I., ERDOGAN, O. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure. Arq. Bras. Cardiol. 2015; (June 2012):606–613.
- 29. FU, S., XIE, L., LI, D., YE, P., LUO, L. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure. Clin. Interv. Aging 2015; 10:359–365.
- 30. HUANG, W.M., CHENG, H.M., HUANG, C.J., GUO, C.Y., LU, D.Y., LEE, C.W., et al. Hemographic indices are associated with mortality in acute heart failure /692/4019/592/75/74 /692/4019/592/75/230 article. Sci. Rep. 2017; 7(1):1–9.
- 31. AVCI, A., ALIZADE, E., FIDAN, S., YESIN, M., GULER, Y. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy. Scand Cardiovasc J 2014; 48(4):202–8.
- 32. YILDIZ, A., YÜKSEL, M., OYLUMLU, M., POLAT, N., AKIL, M.A., ACET, H. The association between the neutrophil/lymphocyte ratio and functional capacity in patients with idiopathic dilated cardiomyopathy. Anadolu Kardiyol. Derg. 2015; 15(1):13–17.
- 33. SOBRINO-MÁRQUEZ, J.M., GRANDE-TRILLO, A., CANTERO-PÉREZ, E.M., RANGEL-SOUSA, D., LAGE-GALLE, E., ADSUAR-GÓMEZ, A. Prognostic value of blood panel parameters in patients with dilated cardiomyopathy and advanced heart failure. Transplant. Proc. 2018; 50(2):650–652.
- 34. YAN, W., LIU, C., LI, R., MU, Y., JIA, Q., HE, K. Usefulness of the neutrophil-to-lymphocyte ratio in predicting adverse events in elderly patients with chronic heart failure. Int. Heart J. 2016; 57(5):615–621.
- 35. YAN, W., LI, R.J., JIA, Q., MU, Y., LIU, C.L., HE, K.L. Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure. J. Geriatr. Cardiol. 2017; 14(2):127–134.
- 36. SAROJINI, A., SAI RAVI SHANKER, A., ANITHA, M. Inflammatory markers-serum level of c-reactive protein, tumor necrotic factor-α, and interleukin-6 as predictors of outcome for peripartum cardiomyopathy. J. Obstet. Gynecol. India 2013; 63(4):234–239.
- 37. AZIBANI, F., SLIWA, K. Peripartum cardiomyopathy: an update. Curr. Heart Fail. Rep. 2018; 15(5):297–306.
- 38. GÜRKAN, U., AKGÖZ, H., AKSOY, Ş., CAN GÜRKAN, Ö., OSKEN, A., UNAL DAYI, S., et al. Value of the neutrophil-tolymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy. Wien. Klin. Wochenschr. 2017; 129(23–24):893–899.
- 39. URAL, D. Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy. Med. Sci. Monit. 2013; 19:373–377.
- 40. BALCI, K.G., BALCI, M.M., SEN, F., CANPOLAT, U., AKBOGA, M.K., UNAL, S., et al. The role of baseline indirect inflammatory markers in prediction of response to cardiac resynchronisation therapy. Kardiol. Pol. 2016; 74(2):119–126.
- 41. BOROS, A.M., SZÉPLAKI, G., PERGE, P., JENEI, Z., BAGYURA, Z., ZIMA, E., et al. The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy. Europace 2016; 18(5):747–754.
- 42. HASHIMOTO, N., ARIMOTO, T., NARUMI, T., IWAYAMA, T., KUTSUZAWA, D., ISHIGAKI, D., et al. The neutrophil-tolymphocyte ratio predicts all-cause mortality in patients with implantable cardioverter defibrillators. PACE – Pacing Clin. Electrophysiol. 2017; 40(2):135–144.
- 43. UCAR, F., ACAR, B. Neutrophil to lymphocyte ratio predicts appropriate therapy in idiopathic dilated cardiomyopathy patients with primary prevention implantable cardioverter defibrillator. Saudi Med J 2017; 38(2):143–148.
- 44. YOST, G., JOSEPH, C., TATOOLES, A., BHAT, G. Neutrophil-to-lymphocyte ratio predicts outcomes in patients implanted with left ventricular assist devices. ASAIO J. 2015; 61:664–9.
- 45. BHAT, G., YOST, G.L., IBRAHIM, K., PAPPAS, P., TATOOLES, A. Risk stratification with longitudinal neutrophil to lymphocyte ratio assessment after left ventricular assist device implantation. Int. J. Artif. Organs 2018; 41(8):445–451.
- 46. FERRERA, C., GONZALEZ FERNANDEZ, O., BOUZAS, N., CASTRODEZA, J., GREEN, T., WOODS, A., et al. Neutrophil to lymphocyte ratio is related to thrombotic complications and survival in continuous flow left ventricular assist devices. ASAIO J. 2019; [Epub ahead of print]
- 47. SUNDARARAJAN, S., KIERNAN, M.S., COUPER, G.S., UPSHAW, J.N., DENOFRIO, D., VEST, A.R. The neutrophillymphocyte ratio and survival during left ventricular assist device support. J. Card. Fail. 2019; 25(3):188–194.
- 48. KARACAGLAR, E., BAL, U., CIFTCI, O., TURGAY, O., YILMAZ, M., SADE, E., et al. Predictive value of hematologic parameters for detecting asymptomatic graft rejection after heart transplant: Preliminary results. Exp. Clin. Transplant. 2015; 13:146–148.
- 49. CHOI, D.-H., KOBAYASHI, Y., NISHI, T., LUIKART, H., DIMBIL, S., KOBASHIGAWA, J., et al. Change in lymphocyte to neutrophil ratio predicts acute rejection after heart transplantation. Int. J. Cardiol. 2018; 251:58–64.
- 50. SEROPIAN, I.M., ROMEO, F.J., PIZARRO, R., VULCANO, N.O., POSATINI, R.A., MARENCHINO, R.G., et al. Neutrophilto-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation. ESC Hear. Fail. 2018; 5(1):149–156.
- 51. ARGAN, O., URAL, D., KOZDAG, G., SAHIN, T., BOZYEL, S., AKTAS, M., et al. Associations between neutrophil gelatinase associated lipocalin, neutrophil-to-lymphocyte ratio, atrial fibrillation and renal dysfunction in chronic heart failure 2016; 4765–4772.